LimsLink connects laboratory systems enabling Genzyme to capture and process large amounts of product data while complying with FDA regulations
Labtronics reports that Genzyme has chosen its LimsLink software to provide the integration capabilities required to achieve the goal of creating a global product data management system.
Genzyme is one of the world's top biotechnology companies, and its rapid growth has resulted in many regulated products both in the marketplace and in its pipeline.
This has created an increase in the amount of product data that they need to capture, process and archive by several orders of magnitude over the past few years.
Genzyme recognised that it needed to ensure that these large volumes of product data could be managed effectively and efficiently while also complying with the many regulations inherent in their industry.
Genzyme determined that it needed to create a global product data management system that consists of many laboratory systems working together as a cohesive system.
It implemented a new laboratory information management system (Lims) and scientific data management system (SDMS) to deal with the massive amounts of data being generated by its laboratory instruments, recognising the need that these instruments and systems communicate in order to leverage their technology investment.
Genzyme chose Labtronics's LimsLink laboratory data integration to provide the required communication capabilities.
LimsLink can provide a bi-directional connection between all of the company's laboratory instruments and their management systems, both Lims and SDMS.
The automation of test results downloaded from lab instruments to management systems enables Genzyme to eliminate human error in data entry and to increase lab productivity.
LimsLink is also fully compliant with the regulations that biotechnology companies have to comply with including FDA 21 CFR Part 11.
"LimsLink is an integral part of our global product management", said Bennett Green, senior vice president of global quality operations at Genzyme.
"We have successfully tested and validated the complete solution in many of our labs and are now continuing to deploy the solution across additional locations around the world".
"This was a very strategic project for Genzyme and we are honoured that LimsLink was chosen as their integration standard, said Robert Pavlis, president of Labtronics.
"We are looking forward to continuing to work closely with Genzyme as it rolls this software out to all of its laboratories.
